
Abbott to sell generics in major markets to Mylan for $5.3 billion
Abbott Laboratories has agreed to sell its specialty and branded generic pharmaceutical business in developed markets to Pennsylvania-based Mylan Inc. in an all-stock transaction valued at about $5.3 billion. The...


